Erasca, Inc. (ERAS)
NASDAQ·Healthcare·Biotechnology
$16.04
+0.09%
Mkt Cap $5.62B
Analyst Ratings
Buy
5
Hold
4
Sell
0
Price Target (17 analysts)
$17.50
Range $10.00 – $30.00
Implied Upside
+9.1%
Consensus $17.50 vs current $16.04
NASDAQ·Healthcare·Biotechnology
$16.04
+0.09%
Mkt Cap $5.62B
Buy
5
Hold
4
Sell
0
Price Target (17 analysts)
$17.50
Range $10.00 – $30.00
+9.1%
Consensus $17.50 vs current $16.04